FIELD: pharmaceuticals.
SUBSTANCE: invention relates to 5-(3-chloro-4-fluorophenyl)-7-cyclopropyl-3-(2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one formula
and pharmaceutically acceptable salt thereof. Also a pharmaceutical composition containing the said compound or a pharmaceutically acceptable salt thereof are provided.
EFFECT: proposed compound is capable of modulating the activity of NMDA receptors and can be used in the treatment of psychiatric, neurological and neurodevelopmental disorders, as well as nervous system diseases.
12 cl, 2 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | 2016 |
|
RU2735277C2 |
| PYRIDOPYRIMIDINONES AND USE THEREOF AS MODULATORS OF N-METHYL-D-ASPARTATE RECEPTOR | 2016 |
|
RU2717665C2 |
| SUBSTITUTED DIHYDRO BENZOCYCLOALKYLOXYMETHYL OXAZOLOPYRIMIDINONE, PREPARING AND USING THEM | 2010 |
|
RU2543384C2 |
| CYCLOPROPYLPIPERIDINE GLYCINE TRANSPORTER INHIBITORS | 2005 |
|
RU2387644C2 |
| AMIDE DERIVATIVES OF CARBOXYLIC ACID, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2001 |
|
RU2271361C2 |
| COMPOUNDS AND METHODS | 2015 |
|
RU2711442C2 |
| POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2017 |
|
RU2750935C2 |
| 3-FLUOROPIPERIDINES AS NMDA/NR2B ANTAGONISTS | 2004 |
|
RU2339630C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| PYRROLOPYRIMIDINE COMPOUNDS AND APPLICATION THEREOF | 2011 |
|
RU2563644C2 |
